280 related articles for article (PubMed ID: 21929543)
1. High-throughput resequencing of target-captured cDNA in cancer cells.
Ueno T; Yamashita Y; Soda M; Fukumura K; Ando M; Yamato A; Kawazu M; Choi YL; Mano H
Cancer Sci; 2012 Jan; 103(1):131-5. PubMed ID: 21929543
[TBL] [Abstract][Full Text] [Related]
2. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
3. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
4. Deep sequencing in cancer research.
Yoshida K; Sanada M; Ogawa S
Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
[TBL] [Abstract][Full Text] [Related]
5. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.
Summerer D; Schracke N; Wu H; Cheng Y; Bau S; Stähler CF; Stähler PF; Beier M
Genomics; 2010 Apr; 95(4):241-6. PubMed ID: 20138981
[TBL] [Abstract][Full Text] [Related]
6. Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis.
Liu S; Mirza A; Wang L
Methods Mol Biol; 2004; 281():33-54. PubMed ID: 15220520
[TBL] [Abstract][Full Text] [Related]
7. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y; Bodmer WF
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
[TBL] [Abstract][Full Text] [Related]
8. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
[TBL] [Abstract][Full Text] [Related]
9. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
10. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
11. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
Bainbridge MN; Warren RL; Hirst M; Romanuik T; Zeng T; Go A; Delaney A; Griffith M; Hickenbotham M; Magrini V; Mardis ER; Sadar MD; Siddiqui AS; Marra MA; Jones SJ
BMC Genomics; 2006 Sep; 7():246. PubMed ID: 17010196
[TBL] [Abstract][Full Text] [Related]
13. Exome versus transcriptome sequencing in identifying coding region variants.
Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA.
Contos JJ; Chun J
Genomics; 2000 Mar; 64(2):155-69. PubMed ID: 10729222
[TBL] [Abstract][Full Text] [Related]
15. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
[TBL] [Abstract][Full Text] [Related]
16. Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing.
Greif PA; Eck SH; Konstandin NP; Benet-Pagès A; Ksienzyk B; Dufour A; Vetter AT; Popp HD; Lorenz-Depiereux B; Meitinger T; Bohlander SK; Strom TM
Leukemia; 2011 May; 25(5):821-7. PubMed ID: 21339757
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
[TBL] [Abstract][Full Text] [Related]
18. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]